Skip to main content
Clinical Trials/ACTRN12616000690459
ACTRN12616000690459
Completed
N/A

Efficacy of resistance training for the prevention of cognitive decline in healthy older adults.

Murdoch University0 sites45 target enrollmentMay 26, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cognitive decline
Sponsor
Murdoch University
Enrollment
45
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Considered low to moderate risk for moderate intensity exercise as per Exercise and Sports Science Australia risk stratification. Participants should be considered healthy.

Exclusion Criteria

  • 1\.Have more than two risk factors in the Exercise and Sports Science Australia pre\-exercise screening tool questionnaire
  • 2\.Present with chronic musculoskeletal disease or injury
  • 3\.Show signs of mild cognitive impairment or dementia
  • 4\.Are a current smoker
  • 5\.Are currently taking selective serotonin reuptake inhibitor medication (Citalopram \[Celexa], Escitalopram \[Lexapro], Fluoxetine \[Prozac], Paroxetine \[Paxil, Pexeva] or Sertraline \[Zoloft])
  • 6\.Have a history of neurological disease

Outcomes

Primary Outcomes

Not specified

Similar Trials